May I also add, before Covid, very few made such a fuss or seemed to be that concerned about those undergoing chemo or any immunosuppressant treatment?
Before COVID-19 and the pressures on ICU/HDU and hospitals in general, I wonder if the immunocompromised/immunosuppressed
*had some confidence that they would have access to treatment because their local hospitals would be experiencing 'normal' Winter overwhelm rather than COVID-19 levels of overwhelm
*we now have more people, plausibly, who are at later stages of, for example, CKD etc. and awaiting a transplant or putting pressure on related services such as dialysis
*we now have a greater number of clinically frail people (whether by age, by condition, or by virtue of being someone who is living successfully with a condition that would previously have killed them at an earlier age).
The Evusheld #Forgotten500K campaign estimates there are 500,000 people who are high risk/clinically extremely vulnerable. The Independent Advisory Group estimates it as @ 150,000. Other countries make Evusheld available as a prophylactic to the relatively vulnerable which includes all over-50s (that would be >26million for England, might be UK).
getevusheld.uk/500k/
I don't know anything about it but it looks like NICE is looking at it in January 2023 for the Winter of 2023.
www.nice.org.uk/guidance/indevelopment/gid-ta11102
It looks like there's a lot of controversy about whether it works.
Vulnerable people have reported feeling forgotten and there’s a strong argument that the UK government should rethink its COVID strategy on a moral and public health basis. We should invest in new drugs, not withdraw them prematurely. Evusheld may not be perfect, but what alternative is there for an equal chance to “live” amid a now unmitigated pandemic?
theconversation.com/covid-drugs-the-uks-treatment-and-prevention-options-and-how-vulnerable-people-are-being-forgotten-195415